FDA approves Medicines Co's urinary tract infection drug

(Reuters) – The U.S. Food and Drug Administration said on Tuesday it has approved Medicines Co’s antibacterial drug for patients with complicated urinary tract infections (cUTI).


Source: Reuters Health News